Disease associated variation - GWASdb |
Chr | Pos | SNP ID(dbSNP 142) | Ref | Alt | Ori SNP ID | P-value | Drug Name | Drug Anno | GWAS Trait | HPO ID | DO ID | AA | Type | Trait or Drug |
10 | 105075712 | rs12220267 | C | T | rs12220267 | 1.00E-213 | | | Arsenic metabolism and toxicity | HPOID:0011013 | DOID:0050032 | C | intron | GWASdb_trait |
10 | 105080575 | rs7093667 | T | C | rs7093667 | 8.90E-05 | | | White matter hyperintensity burden | HPOID:0007103|HPOID:0002637 | DOID:936|DOID:2316|DOID:3527 | C | intron | GWASdb_trait |
10 | 105092447 | rs10883855 | T | C | rs10883855 | 7.70E-05 | | | White matter hyperintensity burden | HPOID:0007103|HPOID:0002637 | DOID:936|DOID:2316|DOID:3527 | C | intron | GWASdb_trait |
10 | 105101701 | rs11191659 | C | T | rs11191659 | 0.0009 | | | Urinary concentrations of arsenic metabolites (percentage monomethylarsonic acid) | HPOID:0011013 | DOID:0050032 | C | intron | GWASdb_trait |
10 | 105101701 | rs11191659 | C | T | rs11191659 | 1.04E-12 | | | Arsenic metabolism and toxicity | HPOID:0011013 | DOID:0050032 | C | intron | GWASdb_trait |
10 | 105101701 | rs11191659 | C | T | rs11191659 | 3.29E-12 | | | Arsenic metabolism and toxicity | HPOID:0011013 | DOID:0050032 | C | intron | GWASdb_trait |